GGrantIndex
Sort

48,018 grants matching immunotherapy

Regulation of Lymphocyte Development by HLH Proteins

$434,219
Barbara Lynne Kee · University Of Chicago · R01 · FY2016 · AI

Engineered bacterial in situ vaccines against oral cancer.

$434,170
Simon Young · University Of Texas Hlth Sci Ctr Houston · R21 · FY2024 · DE

EAMG: MIR structure and specific immunosuppressive therapy

$434,037
Jon Martin Lindstrom · University Of Pennsylvania · R01 · FY2007 · NS

Synthetics PNAG and multi-component vaccines against emerging pathogens

$434,004
Gerald B Pier · Harvard Medical School · U54 · FY2009 · AI

Immunotherapy for Drug Abuse

$433,975
S. Michael Owens · Univ Of Arkansas For Med Scis · R01 · FY2006 · DA

SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)

$433,973
Richard W Roberts · University Of Southern California · R01 · FY2013 · CA

Autophagy mediated immune stimulation by reovirus in KRAS mutated colorectal cancer

$433,953
Radhashree Maitra · Yeshiva University · R15 · FY2022 · CA

Modulation of Mcl-1 for Treatment of Lung Cancer

$433,907
Xingming Deng · Emory University · R01 · FY2025 · CA

Developmental Funds

$433,838
Edward Chu · Albert Einstein College Of Medicine · P30 · FY2025 · CA

Intra- and inter-cellular signals that drive hepato-oncogenesis

$433,831
Gen-Sheng Feng · University Of California, San Diego · R01 · FY2022 · CA

Studies of Inherited Causes of Fungal Susceptability

$433,819
Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy

$433,777
Gary D Kao · University Of Pennsylvania · R01 · FY2016 · CA

Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy

$433,777
Gary D Kao · University Of Pennsylvania · R01 · FY2018 · CA

Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy

$433,777
Gary D Kao · University Of Pennsylvania · R01 · FY2020 · CA

Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy

$433,777
Gary D Kao · University Of Pennsylvania · R01 · FY2017 · CA

Project 2: Combined CAR-T cell therapy

$433,764
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA

PROJECT 2: NF1-associated Glioblastoma

$433,758
Luis F Parada · Indiana University Indianapolis · U54 · FY2021 · CA

Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI

$433,750
Alan David Hutson · Roswell Park Cancer Institute Corp · U24 · FY2023 · CA

Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies

$433,679
Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Developmental Funds

$433,659
Steven E Artandi · Stanford University · P30 · FY2022 · CA

Developmental Funds

$433,659
Steven E Artandi · Stanford University · P30 · FY2023 · CA

Developmental Funds

$433,659
Steven E Artandi · Stanford University · P30 · FY2024 · CA

Metabolic Control of Innate and Adaptive Immunity in Breast Cancer

$433,609
Guangyong Peng · Washington University · R01 · FY2023 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$433,599
Fox Chase Cancer Center · U10 · FY2001 · CA

High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer

$433,516
Cesar M Castro · Massachusetts General Hospital · R01 · FY2023 · CA